Chongqing Zhifei Biological Products Co., Ltd. Share Price
Equities
300122
CNE100000V20
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.8 CNY | -0.09% | -1.18% | -46.33% |
Sales 2024 * | 58.19B 8.04B 631B | Sales 2025 * | 64.49B 8.91B 700B | Capitalization | 78.52B 10.84B 852B |
---|---|---|---|---|---|
Net income 2024 * | 10.4B 1.44B 113B | Net income 2025 * | 12.57B 1.74B 136B | EV / Sales 2024 * | 1.21 x |
Net cash position 2024 * | 7.86B 1.09B 85.3B | Net cash position 2025 * | 14.74B 2.04B 160B | EV / Sales 2025 * | 0.99 x |
P/E ratio 2024 * |
7.67
x | P/E ratio 2025 * |
6.39
x | Employees | 6,545 |
Yield 2024 * |
2.79% | Yield 2025 * |
3.04% | Free-Float | 14.73% |
1 day | -0.09% | ||
1 week | -1.18% | ||
1 month | -6.55% | ||
3 months | -38.14% | ||
6 months | -49.00% | ||
Current year | -46.33% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Ping Xu
CHM | Chairman | 43 | 31/12/13 |
Zhen Jing Li
DFI | Director of Finance/CFO | 42 | 31/12/13 |
Ren Sheng Jiang
CHM | Chairman | 71 | 16/08/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 71 | 16/08/09 |
Ling Feng Jiang
BRD | Director/Board Member | 44 | 31/07/12 |
Lin Du
BRD | Director/Board Member | 59 | 10/04/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.58% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 32.8 | -0.09% | 12,763,200 |
30/05/24 | 32.83 | -0.39% | 9,468,116 |
29/05/24 | 32.96 | -0.18% | 9,426,398 |
28/05/24 | 33.02 | -0.36% | 12,138,420 |
27/05/24 | 33.14 | -0.15% | 16,096,680 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.33% | 10.84B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
+5.77% | 9.11B | |
-17.66% | 7.32B | |
+88.73% | 7.14B |
- Stock Market
- Equities
- 300122 Stock